BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 21816781)

  • 1. Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis.
    Wu VC; Lo SC; Chen YL; Huang PH; Tsai CT; Liang CJ; Kuo CC; Kuo YS; Lee BC; Wu EL; Lin YH; Sun YY; Lin SL; Chen JW; Lin SJ; Wu KD;
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3175-83. PubMed ID: 21816781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability.
    Verhovez A; Zeoli A; Williams TA; Morello F; Brizzi MF; Veglio F; Mulatero P
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):528-34. PubMed ID: 18410543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans.
    Thum T; Schmitter K; Fleissner F; Wiebking V; Dietrich B; Widder JD; Jazbutyte V; Hahner S; Ertl G; Bauersachs J
    Eur Heart J; 2011 May; 32(10):1275-86. PubMed ID: 20926363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.
    Lin YH; Lin LY; Chen A; Wu XM; Lee JK; Su TC; Wu VC; Chueh SC; Lin WC; Lo MT; Wang PC; Ho YL; Wu KD;
    Atherosclerosis; 2012 Mar; 221(1):154-9. PubMed ID: 22197109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone Impairs Vascular Smooth Muscle Function: From Clinical to Bench Research.
    Chou CH; Chen YH; Hung CS; Chang YY; Tzeng YL; Wu XM; Wu VC; Tsai CT; Wu CK; Ho YL; Wu KD; Lin YH;
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4339-47. PubMed ID: 26401591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients.
    Rossi GP; Bolognesi M; Rizzoni D; Seccia TM; Piva A; Porteri E; Tiberio GA; Giulini SM; Agabiti-Rosei E; Pessina AC
    Hypertension; 2008 May; 51(5):1366-71. PubMed ID: 18347224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: prospective study of 102 patients.
    Liao CW; Lin LY; Hung CS; Lin YT; Chang YY; Wang SM; Wu VC; Wu KD; Ho YL; Satoh F; Lin YH
    Sci Rep; 2016 Feb; 6():20862. PubMed ID: 26883298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenalectomy improves arterial stiffness in primary aldosteronism.
    Strauch B; Petrák O; Zelinka T; Wichterle D; Holaj R; Kasalický M; Safarík L; Rosa J; Widimský J
    Am J Hypertens; 2008 Oct; 21(10):1086-92. PubMed ID: 18654122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypokalemia correlated with arterial stiffness but not microvascular endothelial function in patients with primary aldosteronism.
    Chang YY; Chen A; Chen YH; Hung CS; Wu VC; Wu XM; Lin YH; Ho YL; Wu KD;
    J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):353-9. PubMed ID: 25143326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary aldosteronism: functional histopathology and long-term follow-up after unilateral adrenalectomy.
    Volpe C; Hamberger B; Höög A; Mukai K; Calissendorff J; Wahrenberg H; Zedenius J; Thorén M
    Clin Endocrinol (Oxf); 2015 May; 82(5):639-47. PubMed ID: 25347939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience.
    Sukor N; Gordon RD; Ku YK; Jones M; Stowasser M
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2437-45. PubMed ID: 19401369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism.
    Lin YH; Wu XM; Lee HH; Lee JK; Liu YC; Chang HW; Lin CY; Wu VC; Chueh SC; Lin LC; Lo MT; Ho YL; Wu KD;
    J Hypertens; 2012 Aug; 30(8):1606-13. PubMed ID: 22688266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokines and cardiometabolic profile in primary hyperaldosteronism.
    Iacobellis G; Petramala L; Cotesta D; Pergolini M; Zinnamosca L; Cianci R; De Toma G; Sciomer S; Letizia C
    J Clin Endocrinol Metab; 2010 May; 95(5):2391-8. PubMed ID: 20194710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
    Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
    Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary aldosteronism -- screening, diagnosis and therapy.
    Horký K; Gregorová I; Vancura J; Silinková-Málková E; Hradec E
    Cor Vasa; 1981; 23(4):265-79. PubMed ID: 7028394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial progenitor cells in patients with essential hypertension.
    Delva P; Degan M; Vallerio P; Arosio E; Minuz P; Amen G; Di Chio M; Lechi A
    J Hypertens; 2007 Jan; 25(1):127-32. PubMed ID: 17143183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperaldosteronism is associated with a decrease in number and altered growth factor expression of endothelial progenitor cells in rats.
    Ladage D; Schützeberg N; Dartsch T; Krausgrill B; Halbach M; Zobel C; Müller-Ehmsen J
    Int J Cardiol; 2011 Jun; 149(2):152-156. PubMed ID: 20116868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Number and function of circulating endothelial progenitor cell in diabetics with different vascular complications].
    Chen LL; Liao YF; Zeng TS; Li YM; Yu F; Li HQ
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1234-9. PubMed ID: 19595175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.
    ; Wu VC; Chueh SC; Chang HW; Lin LY; Liu KL; Lin YH; Ho YL; Lin WC; Wang SM; Huang KH; Hung KY; Kao TW; Lin SL; Yen RF; Chen YM; Hsieh BS; Wu KD
    Am J Kidney Dis; 2009 Oct; 54(4):665-73. PubMed ID: 19628318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.